TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-5.63%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.54B
AUM Growth
+$2.54B
(-11%)
Cap. Flow
-$63M
Cap. Flow
% of AUM
-2.48%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
180
New
5
Increased
28
Reduced
33
Closed
3
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$14.8M |
| 2 |
Intuitive Surgical
ISRG
|
$9.75M |
| 3 |
AstraZeneca
AZN
|
$8.86M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$8.43M |
| 5 |
Boston Scientific
BSX
|
$8.42M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$24M |
| 2 |
McKesson
MCK
|
$14.8M |
| 3 |
Eli Lilly
LLY
|
$11.5M |
| 4 |
Medtronic
MDT
|
$9.78M |
| 5 |
Waters Corp
WAT
|
$8.23M |
Sector Composition
| 1 | Healthcare | 95.42% |
| 2 | Real Estate | 3.13% |
| 3 | Industrials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
BioNTech
BNTX
$24B
| $14.2M | 0.56% | 95,042 | – | – |
|
52
Apellis Pharmaceuticals
APLS
$3.48B
| $14.1M | 0.55% | 312,192 +116,372 | +59% | +$5.26M |
|
|
ITCI
53
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $13.9M | 0.55% | 243,437 -47,499 | -16% | -$2.71M |
|
54
Ventas
VTR
$30.9B
| $12.8M | 0.5% | 248,131 | – | – |
|
55
Novartis
NVS
$245B
| $11.5M | 0.45% | 136,225 | – | – |
|
56
CVS Health
CVS
$92.8B
| $11.5M | 0.45% | 123,803 -23,650 | -16% | -$2.19M |
|
57
BioMarin Pharmaceuticals
BMRN
$11.2B
| $10.6M | 0.42% | 128,004 | – | – |
|
58
Labcorp
LH
$23.1B
| $10.3M | 0.41% | 44,142 | – | – |
|
59
Charles River Laboratories
CRL
$8.04B
| $10.2M | 0.4% | 47,894 -14,096 | -23% | -$3.02M |
|
|
BHVN
60
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.2M | 0.4% | 70,176 | – | – |
|
|
KRTX
61
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $10M | 0.39% | 79,057 -21,401 | -21% | -$2.71M |
|
62
uniQure
QURE
$896M
| $9.72M | 0.38% | 521,693 | – | – |
|
63
DexCom
DXCM
$29.5B
| $9.68M | 0.38% | 129,884 +93,213 | +254% | +$6.95M |
|
64
Owens & Minor
OMI
$378M
| $9.06M | 0.36% | 288,167 | – | – |
|
|
DOC
65
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $8.65M | 0.34% | 495,733 | – | – |
|
66
Omega Healthcare
OHI
$12.6B
| $8.64M | 0.34% | 306,433 | – | – |
|
67
Lantheus
LNTH
$3.73B
| $8.39M | 0.33% | +127,092 | New | +$8.39M |
|
|
ONC
68
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $8.26M | 0.32% | 51,018 | – | – |
|
69
Sabra Healthcare REIT
SBRA
$4.58B
| $7.13M | 0.28% | 510,660 | – | – |
|
70
HealthEquity
HQY
$7.72B
| $7.08M | 0.28% | 115,314 +12,000 | +12% | +$737K |
|
71
Elevance Health
ELV
$71.8B
| $7.07M | 0.28% | 14,644 | – | – |
|
|
LTC
72
LTC Properties
LTC
$1.68B
| $7M | 0.28% | 182,293 | – | – |
|
73
Addus HomeCare
ADUS
$2.12B
| $6.97M | 0.27% | 83,632 | – | – |
|
74
AMN Healthcare
AMN
$796M
| $6.71M | 0.26% | 61,201 | – | – |
|
75
Denali Therapeutics
DNLI
$2.23B
| $6.55M | 0.26% | 222,420 | – | – |
|